{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:21:51Z","timestamp":1792315311207,"version":"4.4.0"},"reference-count":5,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3386,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1111\/j.1365-2257.2006.00788.x","type":"journal-article","created":{"date-parts":[[2006,5,25]],"date-time":"2006-05-25T08:37:48Z","timestamp":1148546268000},"page":"279-281","source":"Crossref","is-referenced-by-count":16,"title":["Isolated limb infusion with cytotoxic agent for treatment of localized refractory cutaneous T-cell lymphoma"],"prefix":"10.1111","volume":"28","author":[{"given":"E.","family":"ELHASSADI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"EGAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"O'SULLIVAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"MOHAMED","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,5,25]]},"reference":[{"key":"10.1111\/j.1365-2257.2006.00788.x-BIB2|cit1","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1245\/aso.2002.9.2.127","article-title":"Prognostic factors after isolated limb infusion with cytotoxic agents for melanoma","volume":"9","author":"Lindn\u00e9r","year":"2002","journal-title":"Annals of Surgical Oncology"},{"key":"10.1111\/j.1365-2257.2006.00788.x-BIB3|cit2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1111\/j.1365-2257.2006.00788.x-BIB4|cit3","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0360-3016(91)90106-E","article-title":"Effects of oxygenation and pH on tumour cell response to alkylating chemotherapy","volume":"20","author":"Siemann","year":"1991","journal-title":"International Journal of Radiation Oncology, Biology, Physics"},{"key":"10.1111\/j.1365-2257.2006.00788.x-BIB5|cit4","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<238::AID-SSU8>3.0.CO;2-9","article-title":"Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion","volume":"14","author":"Thompson","year":"1998","journal-title":"Seminars in Surgical Oncology"},{"key":"10.1111\/j.1365-2257.2006.00788.x-BIB6|cit5","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/bjs.1800831004","article-title":"Thirty-five years of isolated limb perfusion for melanoma: indications and results","volume":"83","author":"Vrouenraets","year":"1996","journal-title":"British Journal of Surgery"}],"container-title":["Clinical &amp; Laboratory Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2257.2006.00788.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2257.2006.00788.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T03:01:47Z","timestamp":1625454107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2257.2006.00788.x"}},"subtitle":["<i>Isolated limb infusion for treatment of CTCL<\/i>"],"short-title":[],"issued":{"date-parts":[[2006,5,25]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2257.2006.00788.x","relation":{},"ISSN":["0141-9854"],"issn-type":[{"value":"0141-9854","type":"print"}],"subject":[],"published":{"date-parts":[[2006,5,25]]}}}